Transarterial Chemoembolization of Liver Metastases from Well Differentiated Gastroenteropancreatic Endocrine Tumors with Doxorubicin-eluting Beads: Preliminary Results

Journal of Vascular and Interventional Radiology

Volumn 19, Issue 6, 2008, Pages 855-861

  de Baere, Thierry ^a   Deschamps, Frederic ^a   Teriitheau, Christophe ^a   Rao, Pramod ^a   Conengrapht, Kenneth ^a   Schlumberger, Martin ^a   Leboulleux, Sophie ^a   Baudin, Eric ^a   Hechellhammer, Lukas ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DOXORUBICIN;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILIRUBIN BLOOD LEVEL; CANCER INHIBITION; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DRUG DELIVERY SYSTEM; DRUG ELUTING BEAD; ENDOCRINE TUMOR; FEMALE; FEVER; HUMAN; LIVER METASTASIS; MALE; NAUSEA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; UPPER ABDOMINAL PAIN; VOMITING;

ADULT; AGED; CHEMOEMBOLIZATION, THERAPEUTIC; DISEASE PROGRESSION; DOXORUBICIN; ENDOCRINE GLAND NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HUMANS; LIVER FUNCTION TESTS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; PANCREATIC NEOPLASMS; PROSPECTIVE STUDIES; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 44149113496     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvir.2008.01.030     Document Type: Article

References (31)

1. Tomassetti P., Migliori M., Lalli S., Campana D., Tomassetti V., and Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumours. Ann Oncol 12 suppl 2 (2001) S95-S99
2. Pape U.F., Bohmig M., Berndt U., Tiling N., Wiedenmann B., and Plockinger U. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a german referral center. Ann N Y Acad Sci 1014 (2004) 222-233
3. Mitry E., Baudin E., Ducreux M., et al. Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin. Br J Cancer 81 (1999) 1351-1355
4. Sun W., Lipsitz S., Catalano P., Mailliard J.A., and Haller D.G. Phase II/III study of doxorubicin with fluorouracil compared with streptozocin with fluorouracil or dacarbazine in the treatment of advanced carcinoid tumors: Eastern Cooperative Oncology Group Study E1281. J Clin Oncol 23 (2005) 4897-4904
5. Bajetta E., Catena L., Procopio G., et al. Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?. Cancer Chemother Pharmacol 59 (2007) 637-642
6. Esser J.P., Krenning E.P., Teunissen J.J., et al. Comparison of ((177)Lu-DOTA(0),Tyr(3))octreotate and ((177)Lu-DOTA(0),Tyr(3))octreotide: which peptide is preferable for PRRT?. Eur J Nucl Med Mol Imaging 33 (2006) 1346-1351
7. Van Essen M., Krenning E.P., De Jong M., Valkema R., and Kwekkeboom D.J. Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours. Acta Oncol 46 (2007) 723-734
8. O'Toole D., and Ruszniewski P. Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours. Best Pract Res Clin Gastroenterol 19 (2005) 585-594
9. Mazzaglia P.J., Berber E., Milas M., and Siperstein A.E. Laparoscopic radiofrequency ablation of neuroendocrine liver metastases: a 10-year experience evaluating predictors of survival. Surgery 142 (2007) 10-19
10. van Vilsteren F.G., Baskin-Bey E.S., Nagorney D.M., et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl 12 (2006) 448-456
11. Schurr P.G., Strate T., Rese K., et al. Aggressive surgery improves long-term survival in neuroendocrine pancreatic tumors: an institutional experience. Ann Surg 245 (2007) 273-281
12. Hodul P., Malafa M., Choi J., and Kvols L. The role of cytoreductive hepatic surgery as an adjunct to the management of metastatic neuroendocrine carcinomas. Cancer Control 13 (2006) 61-71
13. Ducreux M., Ruszniewski P., Chayvialle J.A., et al. The antitumoral effect of the long-acting somatostatin analog lanreotide in neuroendocrine tumors. Am J Gastroenterol 95 (2000) 3276-3281
14. Fazio N., de Braud F., Delle Fave G., and Oberg K. Interferon-alpha and somatostatin analog in patients with gastroenteropancreatic neuroendocrine carcinoma: single agent or combination?. Ann Oncol 18 (2007) 13-19
15. Roche A., Girish B.V., de Baere T., et al. Trans-catheter arterial chemoembolization as first-line treatment for hepatic metastases from endocrine tumors. Eur Radiol 13 (2003) 136-140
16. Chamberlain R.S., Canes D., Brown K.T., et al. Hepatic neuroendocrine metastases: does intervention alter outcomes?. J Am Coll Surg 190 (2000) 432-445
17. Gupta S., Johnson M.M., Murthy R., et al. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival. Cancer 104 (2005) 1590-1602
18. Roche A., Girish B.V., de Baere T., et al. Prognostic factors for chemoembolization in liver metastasis from endocrine tumors. Hepatogastroenterology 51 (2004) 1751-1756
19. Hong K., Khwaja A., Liapi E., Torbenson M.S., Georgiades C.S., and Geschwind J.F. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin Cancer Res 12 (2006) 2563-2567
20. Lewis A.L., Taylor R.R., Hall B., Gonzalez M.V., Willis S.L., and Stratford P.W. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J Vasc Interv Radiol 17 (2006) 1335-1343
21. Oken M.M., Creech R.H., Tormey D.C., et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5 (1982) 649-655
22. Soreide O., Berstad T., Bakka A., et al. Surgical treatment as a principle in patients with advanced abdominal carcinoid tumors. Surgery 111 (1992) 48-54
23. Arnold R., Trautmann M.E., Creutzfeldt W., et al. Somatostatin analogue octreotide and inhibition of tumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut 38 (1996) 430-438
24. Moertel C.G., Johnson C.M., McKusick M.A., et al. The management of patients with advanced carcinoid tumors and islet cell carcinomas. Ann Intern Med 120 (1994) 302-309
25. Nobin A., Mansson B., and Lunderquist A. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour. Acta Oncol 28 (1989) 419-424
26. Ruutiainen A.T., Soulen M.C., Tuite C.M., et al. Chemoembolization and bland embolization of neuroendocrine tumor metastases to the liver. J Vasc Interv Radiol 18 (2007) 847-855
27. de Baere T., Dufaux J., Roche A., et al. Circulatory alterations induced by intra-arterial injection of iodized oil and emulsions of iodized oil and doxorubicin: experimental study. Radiology 194 (1995) 165-170
28. de Baere T., Denys A., Briquet R., Chevalier P., Laurent A., and Roche A. Modification of arterial and portal hemodynamic after injection of iodized oil in the hepatic artery: experimental study. J Vasc Interv Radiol 9 (1998) 305-310
29. Johnson P.J., Kalayci C., Dobbs N., et al. Pharmacokinetics and toxicity of intraarterial adriamycin for hepatocellular carcinoma: effect of coadministration of lipiodol. J Hepatol 13 (1991) 120-127
30. Eriksson B.K., Larsson E.G., Skogseid B.M., Lofberg A.M., Lorelius L.E., and Oberg K.E. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 83 (1998) 2293-2301
31. Varela M., Real M.I., Burrel M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46 (2007) 474-481